The global Positive Airway Pressure Devices Market size is expected to reach USD 3.6 billion by 2030, registering a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The healthcare industry is facing challenges owing to the rapidly growing prevalence of obstructive sleep apnea and sleep apnea-associated chronic comorbidities. Obstructive sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. As per the global prevalence of obstructive sleep apnea estimates published in June 2022 by UpToDate, over 936 million individuals across the globe suffer from mild to severe sleep apnea.
Changing lifestyles owing to globalization and the
adoption of unhealthy dietary habits are making individuals prone to obesity,
Cardiovascular diseases (CVDs), diabetes, and hypertension, which are
forerunners of obstructive sleep apnea. As per the estimates published by the
World Population Review, 36.2% of the U.S. population is diagnosed as obese. In
addition, the rapidly increasing geriatric population coupled with increasing
life expectancy is anticipated to contribute to the incidence rate of
obstructive sleep apnea and directly drive the demand for positive airway
pressure devices (PAP) devices. The COVID-19 pandemic restrained the growth of
the market owing to multiple lockdowns and travel restrictions imposed by
governments across the globe to curb the transmission rate.
In addition, the postponement of elective procedures
and infrastructural changes in healthcare facilities to accommodate COVID-19
care facilities negatively impacted the procedural volume, which hindered
market growth. Healthcare facilities and sleep centers recorded a declining
trend in diagnostic and therapeutic procedural volume, restricting the growth
of PAP devices. The American Academy of Sleep Medicine (AASM) introduced
protocols to adopt virtual consultations to address the declining sleep studies
volume. However, during the initial months of the pandemic, PAP machines were
being used as the first line of treatment and as an alternative to ventilators
in mechanical ventilation. Global government bodies are devising strategies to
promote awareness levels among the population and promote the adoption of PAP
machines. The availability of favorable reimbursement policies is further
boosting product adoption.
Related Press Release@ Positive Airway Pressure Devices Market Report
Positive Airway Pressure Devices
Market Report Highlights
- The CPAP devices segment dominated the market in 2021 owing to the
growing incidence of obstructive sleep apnea and CPAP is the first line of
treatment as it is more economical than other PAP devices
- North America dominated the market in 2021 owing to the large
patient pool, increasing disposable income levels, and presence of
favorable insurance coverages
- The prevalence of obstructive sleep apnea in the male population of
North America is recorded to be 15-30% and in females, it is 10-15%
- Key participants in the market are focusing on innovative product
development strategies to expand their product portfolio and address the
growing demand
- Some of the latest features being incorporated in PAP machines are
noise reduction and softer material to enhance patient comfort and
compliance
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment